Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

MYRIAD GENETICS INC

MYGN Clue Score54
United States Fiscal year ends December CIK 0000899923 Results filed 4 Nov 2026

What the insiders did Net selling

By person

43 insiders · 135 transactions
5.5×

Samraat S. Raha holds 5.5 times base salary in stock. $4.76M of shares against $856.90K in salary for 2025.

Salary from the company's own proxy. The shares are what Samraat S. Raha last reported holding, valued at $4.46, the price Common Stock was last bought or sold at on the open market here, on 8 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Jerry S Lanchbury
See Remarks
—
$24.83M (34) scheduled
−$24.83M
264,324
0.2763%
$1.18M
+147.3%
Mark Christopher Capone
President & C.E.O.
—
$12.73M (7) scheduled
−$12.73M
522,216
0.5460%
$2.33M
+151.7%
Richard M Marsh
E.V.P., General Counsel
—
$9.15M (7) scheduled
−$9.15M
144,174
0.1507%
$642.47K
+35.3%
Paul J Diaz
President and CEO
—
$6.47M (5)
−$6.47M
891,844
0.9324%
$3.97M
—
Dennis Langer
Director
—
$4.53M (10) scheduled
−$4.53M
106,802
0.1117%
$475.93K
+510.3%
Jayne B. Hart
See Remarks
—
$4.28M (7) scheduled
−$4.28M
172,561
0.1804%
$768.97K
+75.6%
Gary A. King
Exec. VP International Ops
—
$4.09M (6) scheduled
−$4.09M
148,397
0.1551%
$661.29K
+39.4%
Richard Bryan Riggsbee
Chief Financial Officer
—
$3.45M (8)
−$3.45M
291,812
0.3051%
$1.30M
+377.2%
John T Henderson
Director
$276.15K (5)
$2.17M (6) scheduled
−$1.89M
78,090
0.0816%
$347.98K
+258.2%
Walter Phd Gilbert
Director
$150.00K (1)
$1.44M (3) scheduled
−$1.29M
54,150
0.0566%
$241.30K
+333.2%
Colleen F Reitan
Director
—
$1.29M (1) scheduled
−$1.29M
152,030
0.1589%
$677.48K
—
Nicole Lambert
Chief Operating Officer
—
$1.13M (8)
−$1.13M
223,993
0.2342%
$998.16K
+752.6%
S. Louise Phanstiel
Director
$744.06K (4)
$1.68M (1) scheduled
−$933.68K
362,652
0.3791%
$1.62M
+26,160%
Daniel K Spiegelman
Director
—
$792.26K (6)
−$792.26K
32,917
0.0344%
$146.68K
—
Bernard Tobin
President Crescendo BioScience
—
$468.48K (1)
−$468.48K
160,636
0.1679%
$715.83K
+33.3%
Alexander Ford
Chief Operating Officer
—
$352.72K (3)
−$352.72K
169,040
0.1767%
$753.28K
+424.6%
Margaret Ancona
EVP, Strategy & Transformation
—
$320.99K (1)
−$320.99K
127,726
0.1335%
$569.17K
—
Paul Parkinson
Fmr EVP Strategy & Innovation
—
$295.60K (1)
−$295.60K
87,407
0.0914%
$389.50K
+13.8%
Rashmi Kumar
Director
—
$276.92K (2) scheduled
−$276.92K
171,889
0.1797%
$765.97K
—
Heinrich Dreismann
Director
—
$270.52K (1)
−$270.52K
231,145
0.2417%
$1.03M
+176.7%
Heinrich Dreismann
Director
—
$201.00K (1)
−$201.00K
83,527
0.0873%
$372.21K
+377.3%
Samraat S. Raha
President and CEO
$199.84K (1)
—
+$199.84K
1,068,083
1.12%
$4.76M
—
Lee Nisley Newcomer
Director
—
$156.86K (1)
−$156.86K
191,842
0.2006%
$854.89K
—
Ralph L McDade
President Myriad RBM, Inc.
—
$61.23K (1)
−$61.23K
142,095
0.1486%
$633.20K
+66.6%
Dale Muzzey
Chief Scientific Officer
—
$54.96K (1)
−$54.96K
326,310
0.3412%
$1.45M
+798.9%
Paul Bisaro
Director
$27.64K (1)
—
+$27.64K
157,142
0.1643%
$700.26K
—
Mark Verratti
Chief Operating Officer
—
—
—
629,646
0.6583%
$2.81M
+6,196%
Brian J Donnelly
Chief Commercial Officer
—
—
—
573,363
0.5994%
$2.56M
—
Vishal Sikri
EVP, Commercial
—
—
—
351,224
0.3672%
$1.57M
+275.7%
Jennifer Lynne Fox
Chief Legal & Corp Strategy
—
—
—
345,334
0.3610%
$1.54M
—
Benjamin Richard Wheeler
Chief Financial Officer
—
—
—
287,193
0.3003%
$1.28M
+715.7%
Shereen Solaiman
Chief People Officer
—
—
—
267,801
0.2800%
$1.19M
—
Raj Jampa
Chief Technology Officer
—
—
—
251,889
0.2633%
$1.12M
—
Scott J. Leffler
Chief Financial Officer
—
—
—
218,393
0.2283%
$973.20K
+26,862%
Daniel Skovronsky
Director
—
—
—
195,507
0.2044%
$871.22K
—
Kevin Richard Haas
Chief Technology Officer
—
—
—
180,022
0.1882%
$802.21K
+454.9%
Benjamin Jackson
Former E.V.P., General Counsel
—
—
—
107,029
0.1119%
$476.94K
+506.4%
Mark Steven Davis
Director
—
—
—
106,665
0.1115%
$475.32K
—
Pamela Wong
Chief Legal Officer
—
—
—
65,002
0.0680%
$289.66K
—
Lawrence C Best
Director
—
—
—
60,790
0.0636%
$270.89K
+247.4%
Eric Santa
Former Chief Growth Officer
—
—
—
56,734
0.0593%
$252.82K
—
Natalie Munk
Chief Accounting Officer
—
—
—
45,167
0.0472%
$201.27K
+77.8%
Walter Lloyd Sanders
President Myriad Oncology
—
—
—
36,195
0.0378%
$161.29K
−9.4%